(Sharecast News) - Consumer healthcare giant Haleon posted weaker-than-expected annual sales on Wednesday, hit by a less severe cold and 'flu season and ongoing softness in the US.
The owner of Panadol, Centrum and Sensodyne, among others, saw organic revenues rise 3% in the year to 31 December, to £11.03bn. Analysts...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE